[1]
S. Pasichnyk and A. Gozhenko, “The experience of using ACE inhibitors and Ca channel blockers in the treatment of hypertension in patients with renal cell carcinoma”, J Educ Health Sport, vol. 12, no. 2, pp. 255–261, Feb. 2022.